U.S. researchers looked at 24.1 million stimulant prescriptions for insured and uninsured attention-deficit/hyperactivity disorder patients, and found that about 2.5% of youths aged 17 and younger and 6% of those aged 18 and older received stimulant drugs in March 2008. Wide variation in treatment prevalence among states and counties indicate disparities between clinical practice guidelines and actual practice, according to the study authors. The findings appear in the journal Psychiatric Services.

Full Story:

Related Summaries